Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Samia Mora, M.D.

Co-Author

This page shows the publications co-authored by Samia Mora and Nader Rifai.
Connection Strength

0.936
  1. Nonfasting Sample for the Determination of Routine Lipid Profile: Is It an Idea Whose Time Has Come? Clin Chem. 2016 Mar; 62(3):428-35.
    View in: PubMed
    Score: 0.162
  2. Lipoprotein(a) and risk of type 2 diabetes. Clin Chem. 2010 Aug; 56(8):1252-60.
    View in: PubMed
    Score: 0.110
  3. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem. 2009 May; 55(5):888-94.
    View in: PubMed
    Score: 0.102
  4. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009 Feb 24; 119(7):931-9.
    View in: PubMed
    Score: 0.100
  5. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation. 2008 Sep 02; 118(10):993-1001.
    View in: PubMed
    Score: 0.097
  6. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Circulation. 2006 Aug 01; 114(5):381-7.
    View in: PubMed
    Score: 0.084
  7. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020 03 26; 58(4):496-517.
    View in: PubMed
    Score: 0.054
  8. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. Atherosclerosis. 2020 02; 294:46-61.
    View in: PubMed
    Score: 0.053
  9. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM. Clin Chem. 2018 07; 64(7):1006-1033.
    View in: PubMed
    Score: 0.048
  10. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2016 Jul; 62(7):930-46.
    View in: PubMed
    Score: 0.041
  11. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016 Jul 01; 37(25):1944-58.
    View in: PubMed
    Score: 0.041
  12. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007 Jul 18; 298(3):309-16.
    View in: PubMed
    Score: 0.022
  13. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem. 2007 May; 53(5):845-51.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.